Subscribe to RSS - Inogen

Inogen

Inogen reports big gains, improves outlook

 - 
08/15/2014

GOLETA, Calif. – Inogen’s focus on direct-to-consumer sales is paying off, CEO Ray Huggenberger says.

Inogen repeats double-digit increase

 - 
08/13/2014

Inogen repeats double-digit increase

GOLETA, Calif. – Inogen increased total revenues 50.8% in the second quarter of 2014, the company reported this week.

People news

 - 
08/08/2014

Dave Cormack, president and CEO of Brightree, has been elected to the AAHomecare board of directors.

Inogen makes play in stationary market

 - 
06/24/2014

GOLETA, Calif. – Inogen has received clearance from the U.S. Food and Drug Administration (FDA) for a home oxygen concentrator called Inogen At Home.

Embrace 'rapid maturity' of oxygen market

 - 
06/20/2014

Whether an oxygen provider won the second round of Medicare competitive bidding or not, the results are the same: a dramatic restructuring of the oxygen business model is necessary for continued viability in the category, market experts say.

Inogen off to ‘strong start’ in 2014

 - 
05/16/2014

GOLETA, Calif. – The first quarter of the year is seasonably slow for many public companies, but not this year, not for Inogen.

Short takes: Brightree, Inogen, Roscoe Medical

 - 
04/04/2014

Atlanta-based Brightree has launched Brightree Home Infusion, a new solution to address the clinical, operational and billing needs of home infusion pharmacies.

Inogen reports double-digit increases

 - 
03/28/2014

GOLETA, Calif. – The impact of competitive bidding is “pretty much behind us,” Inogen President and CEO Raymond Huggenberger said during the company’s first-ever earnings call on March 27.

INGN opens for trading

 - 
02/18/2014

GOLETA, Calif. – Inogen (INGN) opened for trading on the NASDAQ on Feb. 14, pricing about 4.4 million shares of its stock at $16 per share, the low end of an expected range of $16 to $18. On Feb. 18, the company’s stock was trading at $15.28 per share.

In brief: Report cites spike in PAP use, Inogen sets IPO terms

 - 
02/07/2014

WASHINGTON – The number of beneficiaries receiving PAP devices for a one-year time period grew 13%, while the total number of beneficiaries receiving all DMEPOS items during the same period fell 1%, according to a recently released comparative billing report.

Pages